ASX Announcements

Despatch of Entitlement offer Completed

ASX Announcement General iTrack Molteno3 AlphaRET

19 Feb, 2024

Retail Entitlement Offer Booklet

ASX Announcement General iTrack Molteno3 AlphaRET

19 Feb, 2024

Appendix 3B - Proposed Issue of Securities

ASX Announcement General iTrack Molteno3 AlphaRET

14 Feb, 2024

EYE Placement & Institutional Offer Completion

ASX Announcement General iTrack Molteno3 AlphaRET

14 Feb, 2024

Investor Presentation

ASX Announcement General iTrack Molteno3 AlphaRET

12 Feb, 2024

Proposed issue of securities

ASX Announcement General iTrack Molteno3 AlphaRET

12 Feb, 2024

Cleansing Notice - Notice under section 708AA(2)(f) of the Corporations Act 2001 (Cth)

ASX Announcement General iTrack Molteno3 AlphaRET

12 Feb, 2024

Capital Raise for Expansion

ASX Announcement General iTrack Molteno3 AlphaRET

12 Feb, 2024

Trading Halt

ASX Announcement General iTrack Molteno3 AlphaRET

12 Feb, 2024

USA Sales Update

ASX Announcement iTrack

8 Jan, 2024

Response to ASX Aware Query

ASX Announcement General iTrack Molteno3 AlphaRET

4 Jan, 2024

USA Medicare Changes Withdrawn

ASX Announcement General iTrack Molteno3 AlphaRET

29 Dec, 2023

Deferral of Proposed USA Medicare Changes

ASX Announcement General iTrack Molteno3 AlphaRET

8 Dec, 2023

Further Update of Proposed USA Medicare Changes

ASX Announcement General iTrack Molteno3 AlphaRET

28 Nov, 2023

AGM Presentation

ASX Announcement General iTrack Molteno3 AlphaRET

23 Nov, 2023

Further Update on Proposed USA Medicare Changes

ASX Announcement General iTrack Molteno3 AlphaRET

14 Nov, 2023

Trading Halt

ASX Announcement General iTrack Molteno3 AlphaRET

10 Nov, 2023

Proposed USA Medicare Changes

ASX Announcement General iTrack Molteno3 AlphaRET

31 Oct, 2023

Trading Halt

ASX Announcement General iTrack Molteno3 AlphaRET

27 Oct, 2023

Preliminary Clinical Results Shows Potential For Addressable Market

ASX Announcement iTrack

25 Oct, 2023

Notice of Annual General Meeting

ASX Announcement General iTrack Molteno3 AlphaRET

20 Oct, 2023

Date of AGM & Closing Date for Director Nominations

ASX Announcement General iTrack Molteno3 AlphaRET

25 Sept, 2023

INVESTOR WEBINAR PRESENTATION - SHARECAFE

ASX Announcement General iTrack Molteno3 AlphaRET

15 Sept, 2023

Evans & Partners Small Cap Healthcare Conference Presentation

ASX Announcement General iTrack Molteno3 AlphaRET

12 Sept, 2023

EYE FY2023 Appendix 4G and Governance Statement

ASX Announcement General iTrack Molteno3 AlphaRET

28 Aug, 2023

EYE FY2023 Results Announcement

ASX Announcement General iTrack Molteno3 AlphaRET

28 Aug, 2023

EYE FY2023 Results Presentation

ASX Announcement General iTrack Molteno3 AlphaRET

28 Aug, 2023

EYE FY2023 Appendix 4E and Annual Report

ASX Announcement General iTrack Molteno3 AlphaRET

28 Aug, 2023

Investor Webinar Full Year (FY23) Results

ASX Announcement General iTrack Molteno3 AlphaRET

23 Aug, 2023

TechKnow Invest Roadshow Presentation August 2023

ASX Announcement General iTrack Molteno3 AlphaRET

3 Aug, 2023

iTrack™ Advance Sales in the USA Driving Strong Results

ASX Announcement General iTrack Molteno3 AlphaRET

2 Aug, 2023

Investor Presentation - ShareCafe

ASX Announcement General iTrack Molteno3 AlphaRET

19 May, 2023

Application for Quotation of Securities

ASX Announcement General iTrack Molteno3 AlphaRET

5 May, 2023

Cleansing Notice

ASX Announcement General iTrack Molteno3 AlphaRET

5 May, 2023

iTrack Advance First Surgeries and Sales in USA

ASX Announcement General iTrack Molteno3 AlphaRET

1 May, 2023

FDA Clears iTrack Advance for US Launch

ASX Announcement General iTrack Molteno3 AlphaRET

31 Mar, 2023

Notice of General Meeting

ASX Announcement General iTrack Molteno3 AlphaRET

28 Mar, 2023

Application for Quotation of Securities

ASX Announcement General iTrack Molteno3 AlphaRET

8 Mar, 2023

Cleansing Notice

ASX Announcement General iTrack Molteno3 AlphaRET

8 Mar, 2023

Reinstatement to Quotation

ASX Announcement General iTrack Molteno3 AlphaRET

2 Mar, 2023

Proposed issue of securities - 2 March 2023

ASX Announcement General iTrack Molteno3 AlphaRET

2 Mar, 2023

Half Yearly Accounts 31 December 2022

ASX Announcement General iTrack Molteno3 AlphaRET

2 Mar, 2023

Investor Presentation Half Year Results 31 Dec 2022

ASX Announcement General iTrack Molteno3 AlphaRET

2 Mar, 2023

Nova Eye Completes $8m Placement

ASX Announcement General iTrack Molteno3 AlphaRET

2 Mar, 2023

Suspension from Official Quotation

ASX Announcement General iTrack Molteno3 AlphaRET

28 Feb, 2023

Trading Halt

ASX Announcement General iTrack Molteno3 AlphaRET

27 Feb, 2023

For investor enquires please contact:

Mark Flynn
Nova Eye Medical Limited
W +61 416 068 733
mflynn@nova-eye.com

This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More